Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lifely VC is a Brazil-based venture capital firm focused on investing in startups in the food, materials, biotechnology, genetics, nutrition, and broader sustainable supply-chain ecosystem. The firm is positioned as an impact-oriented investor backing technologies intended to remove animals from supply chains and support more sustainable, inclusive industrial systems. Its activity appears to be concentrated in venture investing rather than operating a proprietary drug-development pipeline. While it has exposure to health-, biotech-, and genetics-related companies, Lifely VC itself is not a therapeutics developer, pharmaceutical company, CRO, or CDMO. For biotech analysts, the firm is best understood as a sector-adjacent investor in alternative proteins, biomaterials, and related life-science-enabled sustainability businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lifely VC.